25 - 10 - 2012
Milan - The Barentz Group has  further strengthened its position in Europe with the acquisition of Prochifar srl., of Italy. The company has been taken over by Barentz Service Spa, the Group’s Italian joint venture with local partner Chemservice SpA.
10 - 10 - 2012
Hoofddorp, the Netherlands - Barentz Europe B.V. acquired the majority shares in Agri Nutrition B.V.(The Netherlands) on October 2, 2012.
06 - 09 - 2012
Bečej, Serbia - SojaProtein, the Serbian soya concentrate specialist, officially opened its new state-of-the-art production facility in Bečej, Serbia, on 4 September.
25 - 07 - 2012
For the second time Barentz Pharma, together with our daughter company Forum Products, is exhibiting at the CPhI 2012.

Latest News

06 - 02 - 2020
Barentz international B.V. and Matco Foods Limited officially announce the start of a new Joint Venture in Pakistan, following agreement between both parties. The aim of the new activity is to better serve the rapidly growing Pakistani food processing market with a target group of 200 million citizens. Matco Foods has built up an extended network within the Pakistan local food industry Barentz International offers the broadest high-quality ingredients portfolio within the global life science markets Barentz Pakistan will primarily focus on the markets for Human Nutrition and Pharmaceutical products
26 - 11 - 2019
Barentz announces today that Cinven has agreed to invest in their company. Cinven is a leading international private equity firm focused on building world-class European and global companies. Barentz has a strong market position in a structurally growing market for life science ingredients The Cinven team knows the speciality ingredients distribution market well Cinven recognizes the opportunities for both organic and buy and build growth Financial terms of the transaction are not disclosed  
04 - 11 - 2019
Barentz, a leading distributor of ingredients in the life science markets, is pleased to announce it has acquired a majority shareholding in Czech Republic based IMCoPharma. Highlights: IMCoPharma is a leader in the pharmaceutical ingredients market in the CIS region and Ukraine Both Barentz and IMCoPharma are known for their deep technical knowledge and broad portfolio of pharmaceutical ingredients This strategic investment provides Barentz with the licensing capability to do business with all pharmaceutical companies in this attractive region IMCoPharma considers this acquisition as an opportunity for strengthening its position in this market and creating new opportunities